Cardiovascular risk factors in Secondary Progressive Multiple Sclerosis: a cross-sectional analysis from the MS-STAT2 randomised controlled trial.
Thomas E WilliamsNevin JohnAlberto CalviAlessia BianchiFloriana De AngelisAnisha DoshiSarah L WrightMadiha ShatilaMarios C YiannakasFatima ChowdhuryJonathan StuttersAntonio RicciardiFerran PradosDavid MacManusMarie BraisherJames BlackstoneOlga CiccarelliClaudia A M Gandini Wheeler-KingshottFrederik BarkhofJeremy Chatawaynull nullPublished in: European journal of neurology (2023)
Prematurely achieved CVR is associated with lower normalised brain volumes in SPMS. Future longitudinal analyses of this clinical trial dataset will be important to determine whether CVR predicts future disease worsening.
Keyphrases
- multiple sclerosis
- cardiovascular risk factors
- white matter
- clinical trial
- current status
- study protocol
- cardiovascular disease
- metabolic syndrome
- cell proliferation
- mass spectrometry
- resting state
- phase ii
- randomized controlled trial
- open label
- ms ms
- double blind
- cerebral ischemia
- type diabetes
- cross sectional
- blood brain barrier
- functional connectivity
- subarachnoid hemorrhage